Endocrine Abstracts

In recent years, there has been an increase in patients with metabolic syndrome (MS), which is an urgent medical problem. The severity of the clinical manifestations of MS affects the quality of life of patients, while reducing physical and mental health. Obesity leads to anxiety and depressive disorders, neurosis–like conditions, which contributes to a worsening prognosis of the underlying disease.The aim of the work was to assess the level of anx...

This article discusses the assessment of quality of life, psychological state and anxiety-depressive disorders in patients with metabolic syndrome. It is known that the prevalence of metabolic syndrome in different countries is about 30% and varies from included criteria. The problem of the quality of life of obese and overweight patients is relevant and socially significant. Research Methods The authors present the results of a study of 70 patients with MS and 36 apparently h...

MS, is defined by a combination of abnormalities, such as obesity, arterial hypertension, elevated blood sugar and cholesterol levels, type 2 diabetes mellitus and is not a disease, but represents a group of risk factors that often occur together, increasing the likelihood of severe disease. It is well known that the main reasons for the increase in the incidence of MS is a decrease in physical activity with a high-calorie diet. The aim of the study: Ass...

Metabolic syndrome (MS) is characterized by obesity, hypertension, dyslipidemia, and insulin resistance. The severity of the clinical manifestations of MS affects the quality of life (QoL) of patients, while indicators of physical and mental health decrease. In patients, anxiety and depressive disorders in 80-90% of cases are latent, which can aggravate the course of the underlying disease. The purpose of our work is to study the psycho-emotional status and quality of life in ...

Metabolic syndrome (MS) is an actual problem of modern medicine. It is known that the prevalence of MS varies depending on the criteria used to determine it. It should be noted that the main criterion for MS is the central (abdominal) type of obesity. It is necessary to adapt the existing diagnostic criteria for MS in Russia, because it is necessary to take into account ethnic and genetic differences, national nutritional characteristics in the Russian population, lifestyle an...

The prevalence of MS in different countries is 25–30% and varies depending on the diagnostic criteria used. The severity of the clinical manifestations of MS affects the quality of life (QL) of patients, while the indicators of physical and mental health decrease. The problem of QL of patients suffering from overweight and obesity is relevant and socially significant. Obesity leads to anxiety-depressive disorders, neurosis-like conditions, which contributes to a worsening...

Metabolic syndrome (MS) is a widespread clinical syndrome, the incidence of which is increasing annually in both developing and developed countries. The prevalence of MS among the working population is quite high (20-25%) and tends to increase. The presence of MS increases the risk of developing type II diabetes and cardiovascular diseases, and anxiety and depression are considered as independent risk factors for the development of MS. It has also been found that the prevalenc...

Metabolic syndrome (MS) is a pressing problem of modern medicine. The prevalence of MS has a worldwide tendency to increase and depends on many factors, which explains the difficulty in diagnosis, prevention programs and treatment of this pathology. It has been established that MS has a multifactorial etiology, in which psycho-social factors, genetic and environmental factors are important. At the subclinical stage, functional and biochemical changes associated with MS are rev...

Introduction: Metabolic syndrome (MS) is a common disease with up to 25% of the total adult population and more than 45% of those over 60 years of age. When MS develops a complex of metabolic disorders that contribute to the development of vascular atherosclerotic diseases, such as abdominal obesity, hypertension, insulin resistance, dyslipidemia. Exchange disorders in MS are associated with the development of inflammation in organs and vessels, while the role of neutrophils i...

Introduction: Metabolic syndrome (MS) is a disease that develops in obesity in adult patients with the development of numerous metabolic and vascular disorders. In patients with MS, the risk of developing cardiovascular diseases is increased compared to the general population by 1.78 times as a whole and 2.25 times in women. Currently, the number of overweight children and the development of metabolic complications such as fatty liver, hypertension, and type 2 diabetes are inc...